GB virus type C interactions with HIV: the role of envelope glycoproteins.

GB virus type C interactions with HIV: the role of envelope glycoproteins.
复制标题

DOI:
10.1111/j.1365-2893.2009.01194.x
复制
发表时间:
2009-11
影响因子:
2.5
通讯作者:
Stapleton JT
Stapleton JT
中科院分区:
医学3区
文献类型:
--
作者:
Mohr EL;Stapleton JT

文献摘要

参考文献

被引文献

相似文献

GB virus C/hepatitis G virus (GBV-C/HGV) is the most closely related human virus to hepatitis C virus (HCV). GBV-C is lymphotropic and not associated with any known disease, although it is associated with improved survival in HIV-infected individuals. In peripheral blood mononuclear cells, GBV-C induces the release of soluble ligands for HIV entry receptors (RANTES, MIP-1a, MIP-1b and SDF-1), suggesting that GBV-C may interact with lymphocytes to induce a chemokine and/or cytokine milieu that is inhibitory to HIV infection. Expression of GBV-C envelope glycoprotein E2 in CD4+ T cells or addition of recombinant E2 to CD4 cells recapitulates the HIV inhibition seen with GBV-C infection. Like HCV E2, GBV-C E2 is predicted to be post-translationally processed in the endoplasmic reticulum and is involved with cell binding. The C-termini of GBV-C E1 and E2 proteins contain predicted transmembrane domains sharing features with HCV TM domains. To date, cellular receptor(s) for GBV-C E2 have not been identified. GBV-C E2-mediated HIV inhibition is dose-dependent and HIV replication is blocked at the binding and/or entry step. In addition, a putative GBV-C E2 fusion peptide interferes with HIV gp41 peptide oligomerization required for HIV-1 fusion, further suggesting that GBV-C E2 may inhibit HIV entry. Additional work is needed to identify the GBV-C E2 cellular receptor, characterize GBV-C E2 domains responsible for HIV inhibition, and to examine GBV-C E2-mediated fusion in the context of the entire envelope protein or viral-particles. Understanding the mechanisms of action may identify novel approaches to HIV therapy.
DOI: 10.1099/0022-1317-79-8-1871
发表时间: 1998-08-01
影响因子: 3.8
作者:
Adams, NJ;Prescott, LE;Simmonds, P
通讯作者: Simmonds, P
DOI: 10.1093/emboj/cdf295
发表时间: 2002-06-17
期刊: EMBO JOURNAL
影响因子: 11.4
作者:
Cocquerel, L;de Beeck, AO;Dubuisson, J
通讯作者: Dubuisson, J
DOI: 10.1016/j.abb.2005.06.027
发表时间: 2005-10-15
影响因子: 3.9
作者:
Larios, C;Casas, J;Haro, I
通讯作者: Haro, I
DOI: 10.1128/jvi.68.12.7810-7815.1994
发表时间: 1994-12-01
影响因子: 5.4
作者:
DEKA, N;SHARMA, MD;MUKERJEE, R
通讯作者: MUKERJEE, R
DOI: 10.1097/01.aids.0000180097.50393.df
发表时间: 2005-08-12
期刊: AIDS
影响因子: 3.8
作者:
Jung, S;Knauer, O;Reil, H
通讯作者: Reil, H